The cost of one unit blood transfusion components and cost-effectiveness analysis results of transfusion improvement program
| dc.authorid | İndelen, Cenk/0000-0002-3127-355X | |
| dc.contributor.author | İndelen, Cenk | |
| dc.contributor.author | Kizmaz, Yecim Uygun | |
| dc.contributor.author | Kar, Ahmet | |
| dc.contributor.author | Shander, Aryeh | |
| dc.contributor.author | Kirali, Kaan | |
| dc.date.accessioned | 2025-01-21T16:34:36Z | |
| dc.date.available | 2025-01-21T16:34:36Z | |
| dc.date.issued | 2021 | |
| dc.department | Kırıkkale Üniversitesi | |
| dc.description.abstract | Background: This study aims to analyze the cost of the entire transfusion process in Turkey including evaluation of the cost of transfusion from the perspective of hospital management and determination of savings achieved with the transfusion improvement program. Methods: Invoices, labor, material costs were calculated with micro-costing method, while general production expenses were calculated with gross costing method between January 2018 and December 2019. Unit costs for each blood product were calculated separately by collecting unit acquisition costs, material costs, labor costs, and general production expenses and, then, distributed into six different blood products as follows: erythrocyte suspension, fresh frozen plasma, pooled platelet, apheresis platelet, cryoprecipitate, fresh whole blood. The total costs for 2018 and 2019 were calculated and the savings achieved were estimated. The Turkish Lira was converted into the United States Dollar ($) currency using the purchasing power parity. Results: In 2018/2019, the blood component transfusion cost was $240.90/251.18 for erythrocyte suspension, $120.00/128.67 for fresh frozen plasma, $313.50/322.19 for pooled platelet, $314.24/325.73 for apheresis platelet, $104.95/113.99 for cryoprecipitate, and $189.91/209.09 for fresh whole blood. The total transfusion cost was $6,224,208.33 in 2108 and $5,308,148.43 in 2019. As a result of the transfusion improvement program launched in 2019, the amount of blood components decreased by 23.24%, compared to the previous year, and a saving of $916,059.9 was achieved. Conclusion: The transfusion is a burden for both the hospital management systems and the country's economy. To accurately calculate and manage this economic burden is important for sustainable healthcare services. | |
| dc.identifier.doi | 10.5606/tgkdc.dergisi.2021.20886 | |
| dc.identifier.endpage | 157 | |
| dc.identifier.issn | 1301-5680 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 34104508 | |
| dc.identifier.scopus | 2-s2.0-85106563790 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 150 | |
| dc.identifier.trdizinid | 506100 | |
| dc.identifier.uri | https://doi.org/10.5606/tgkdc.dergisi.2021.20886 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay506100 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12587/23992 | |
| dc.identifier.volume | 29 | |
| dc.identifier.wos | WOS:000645197100004 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Baycinar Medical Publ-Baycinar Tibbi Yayincilik | |
| dc.relation.ispartof | Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_20241229 | |
| dc.subject | Cost; cost-effectiveness; patient blood management; transfusion; transfusion improvement program | |
| dc.title | The cost of one unit blood transfusion components and cost-effectiveness analysis results of transfusion improvement program | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
